Aurora Capital Partners completes acquisition of Sharps Compliance Corp.

Aurora Capital Partners, a middle-market private equity firm based in Los Angelos, announced it has completed its acquisition of Sharps Compliance Corp., a full-service national provider of waste management solutions including medical, pharmaceutical and hazardous waste based in Houston.  

"We are excited to add Sharps' industry-leading solutions to our medical waste platform," says Andrew Wilson, a partner at Aurora. "In addition to creating the industry's leading mail-back solution and growing route-based service, the company's management team was early to identify the need for reliable, controlled disposal of unused medication, establishing Sharps as a pioneer in the sector. We look forward to partnering with the team to capitalize on our platform and selectively pursue add-on acquisitions." 

Founded in 1992, Sharps is a provider of medical waste solutions, including both mail-back and route-based collection services. Aurora says the company's management team has overseen consistent growth over multiple decades, driven by repeat business and a long-term focus on exceptional customer service. Additionally, Sharps developed and manages a proprietary nationwide solution for handling unused medication, which has significantly expanded its customer base and reach in the past several years.   

"Aurora has a proven history of partnering with industry leaders to accelerate growth across business lines and we are honored to work with them moving forward," says Pat Mulloy, CEO of Sharps. "I am confident that their understanding of the medical waste services market, combined with their alignment with our customer-first approach, will allow us to build on our recent growth, expand our customer base and further enhance our innovative solutions offerings."  

As previously announced on Aug. 22, 16,830,657 shares were validly tendered and not withdrawn from Aurora's tender offer, representing about 82 percent of the number of shares that were issued and outstanding as of the expiration date on a fully diluted basis. As a result of the completion of the merger, Sharps has stopped trading on the NASDAQ, effective Aug. 22, and has become a privately held company.  

The transaction marks the fifth Aurora investment specifically within the medical waste management space and follows several recent Aurora investments within the broader business services sector.  

Stifel served as exclusive financial adviser and Gibson, Dunn & Crutcher LLP served as legal advisor to Aurora. Raymond James & Associates Inc. acted as financial adviser and Norton Rose Fulbright U.S. LLP acted as legal advisor to Sharps. Antares arranged the debt financing for the transaction.